SUBSCRIBERS
GIC affiliate, ADIA unit buy minority stake in US$9b pharma company
Published Thu, Apr 27, 2017 · 09:50 PM
Singapore
AN affiliate of Singapore's sovereign wealth fund GIC and a subsidiary of the Abu Dhabi Investment Authority (ADIA) have bought a minority stake in Pharmaceutical Product Development (PPD), valuing the pharmaceutical company at US$9.05 billion.
The stake in the United States-based contract research organisation (CRO) was bought from the affiliates of Hellman & Friedman and the affiliates of The Carlyle Group.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
US announces new restrictions on firearm exports
Central banks will probably only cut half as much as they hiked
US consumer sentiment falls as inflation expectations climb
HSBC wins £1.3 billion suit over Disney film finance scandal
WTO countries to reboot dispute reform negotiations
Fed’s preferred core inflation gauge rose at a brisk pace in March